Dexmedetomidine vs fentanyl as an add-on to bupivacaine for nerve blocks in high-risk patients undergoing above-knee amputation
Official title: The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Ultrasound Guided Peripheral Nerve Blocks as a Solo Anesthetic Technique in High Risk Patients Undergoing Unilateral Above Knee Amputation : A Randomized Double Blinded Study
Run by Kasr El Aini Hospital · NCT07640516 · Data updated 2026-11-12
This study tests whether adding dexmedetomidine or fentanyl to bupivacaine for ultrasound-guided nerve blocks can provide better pain relief for adults with heart or lung disease undergoing above-knee amputation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 64 (estimated) |
| Sponsor | Kasr El Aini Hospital Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT07640516 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with significant cardiac or pulmonary disease scheduled for unilateral above-knee amputation and suitable for a regional nerve block technique.
✕Probably not a fit
Patients without adequate block success or who experience adverse effects from the adjuvants may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares two adjuvants—dexmedetomidine and fentanyl—used with bupivacaine in ultrasound-guided nerve blocks that serve as the sole anesthetic technique for high-risk patients undergoing unilateral above-knee amputation. The blocks target the supra-inguinal fascia iliaca and proximal sciatic nerves to provide anesthesia and analgesia while avoiding general or spinal anesthesia. Eligible participants are adults (≥18) with ASA III–IV, documented cardiac or pulmonary disease, and scheduled AKA, with several exclusion criteria to ensure safety. Outcomes likely focus on analgesic efficacy and safety of the adjuvants in this high-risk surgical setting.
Why it matters
Potential benefit: If successful, the approach could improve pain control and reduce anesthesia-related risks for high-risk AKA patients.
How similar studies have gone: There is existing evidence comparing dexmedetomidine and fentanyl as adjuvants in regional anesthesia, but data in this specific high-risk AKA population is limited, making this approach relatively novel for this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Age ≥18 years * Both sexes * ASA III-IV * Documented cardiac disease (e.g., EF \< 40%, NYHA II or higher) * Documented pulmonary disease (e.g., COPD with FEV1 \< 60%) * Scheduled for above-knee amputations Exclusion Criteria: * Neurological or intellectual disability * Drug abuse * Allergy to study drugs * Pregnancy * Contraindications to regional anesthesia (e.g., coagulopathy, local infection) * Significant renal or hepatic impairment( plts \<75000 or INR \>1.5) * Current anticoagulant therapy * severe haemodynamically unstability at the time of block performance, defined as map \> 65 mmhg but achieved by high-dose vasopressors (e.g., norepinephrine ≥ 0.1 mcg/kg/min) after fluid ressuscitation .
Where it's running
-
KasrELainiH
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: paula atef gobran kamil, MBBCH, M.SC
- Email: paula.atef.gobran.1995@gmail.com
- Phone: 0201276604277
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Opioid-free versus opioid-based anesthesia for children having cleft lip or palate repair
This will test whether opioid-free anesthesia can control pain and reduce emergence agitation in children undergoing cleft lip or palate repairs.
-
Pain relief after CABG: tafalgin versus morphine
This will test whether tafalgin relieves pain after coronary artery bypass surgery as well as morphine in adult patients.
-
Intrathecal dexmedetomidine plus fentanyl with bupivacaine for spinal anesthesia during above-knee amputation
This trial will test whether adding intrathecal dexmedetomidine to fentanyl and bupivacaine gives better and longer pain relief after above-knee amputation for adults with lower-limb sarcoma.
-
Using AI to Improve Walking After Above-Knee Amputation
This program tests whether adding artificial intelligence to gait training helps people with above-knee amputations walk better.
-
Using TENS to restore localized limb sensations and improve phantom limb perception after above- or below-knee amputation
This program tests whether a four-week course of transcutaneous electrical nerve stimulation (TENS) combined with conventional rehabilitation can restore somatotopic sensations and improve phantom limb perception in adults with a single above- or below-knee amputation.
-
Amputation stump microenvironment in people having a non-traumatic above-knee amputation
This project will test whether microdialysis and tissue sampling can map the local biological environment in people having non-traumatic above-knee amputations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.